Oncology & Cancer

Specific protein promotes development of pancreatitis and tumours

Pancreatic cancer is one of the most aggressive forms of cancer and is currently very difficult to treat. However, the last few years have seen advances in the scientific understanding of how this cancer develops at a molecular ...

Oncology & Cancer

Antigen level signals response to chemo for pancreatic cancer

(HealthDay)—A drop in carbohydrate antigen (CA) 19-9 levels of more than 10 percent after two rounds of chemotherapy is associated with longer survival in patients with advanced pancreatic ductal adenocarcinoma (PDAC), ...

Oncology & Cancer

Advanced pancreatic tumors depend on continued oncogene activity

Researchers at Dana-Farber Cancer Institute have shown that advanced pancreatic cancers in mice can't survive without continued expression of a mutant oncogene that "rewires" key metabolic pathways to fuel the cancer cells.

Oncology & Cancer

Metformin use may not improve pancreatic cancer survival

Metformin use did not improve survival of patients with pancreatic ductal adenocarcinoma (PDAC) in a retrospective cohort study, according to data presented at the AACR Annual Meeting 2015, April 18-22.

Oncology & Cancer

What do you know about pancreatic cancer?

November is Pancreatic Cancer Awareness Month, which makes this a good time to learn more about the risk factors for pancreatic cancer and what you can do to keep yourself safe.

page 8 from 12